No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BLCO240517P20000
- 4.90
- -0.20-3.92%
15min DelayClose May 10 16:00 ET
4.90High4.70Low
4.80Open5.10Pre Close10 Volume35 Open Interest20.00Strike Price4.84KTurnover222.96%IV-3.63%PremiumMay 17, 2024Expiry Date4.59Intrinsic Value100Multiplier6DDays to Expiry0.31Time Value100Contract SizeAmericanOptions Type-0.7592Delta0.0667Gamma2.99Leverage Ratio-0.1064Theta-0.0027Rho-2.27Eff Leverage0.0065Vega
Intraday
- 5D
- 1D
News
Express News | Bausch + Lomb : Morgan Stanley Raises Target Price to $18 From $16
Express News | Bausch + Lomb : Morgan Stanley Raises to Overweight From Equal Weight
Express News | Bausch & Lomb Shares Are Trading Higher After Morgan Stanley Upgraded the Stock From Equal-Weight to Overweight and Raised Its Price Target From $16 to $18
American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Wedbush rai
Express News | Morgan Stanley Upgrades Bausch & Lomb to Overweight, Raises Price Target to $18
Bausch + Lomb Corporation (NYSE:BLCO) Just Reported Earnings, And Analysts Cut Their Target Price
After the latest results, the twelve analysts covering Bausch + Lomb are now predicting revenues of US$4.66b in 2024. If met, this would reflect a meaningful 8.1% improvement in revenue compared to the last 12 months.
Comments
In today’s market, one of the biggest winners generating outsized interest is $Emergent BioSolutions(EBS.US$ . This mid-cap biotech company remains a unique turnaround story for investors, and many appear to be placing their bets on this company to come out of the pile as a key winner. Indeed, EBS stock has surged over 70% higher on some intriguing news this afternoon.
The company’s turnaround efforts appear to be receiving a jolt today, wit...
The company’s turnaround efforts appear to be receiving a jolt today, wit...
7
1
1
Upgrades
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgra...
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgra...
7
1
Upgrades
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgr...
• $Argo Group International(ARGO.US$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US$ : Cowen Upgr...
12
2
Upgrades
• $Zymergen(ZY.US$ : JPMorgan Upgrades to Neutral from Underweight
Downgrades
• $Chewy(CHWY.US$: Wedbush Downgrades to Neutral from Outperform - PT $44 (from $35)
• $Paramount Global-B(PARA.US$: Goldman Sachs Downgrades to Sell from Buy - PT $20 (from $37)
• $Roku Inc(ROKU.US$: Wolfe Research Downgrades to Underperform from Peerperform - PT $77
• $UBS Group(UBS.US$: BofA Securities Downgrades to Neutral from Buy - P...
• $Zymergen(ZY.US$ : JPMorgan Upgrades to Neutral from Underweight
Downgrades
• $Chewy(CHWY.US$: Wedbush Downgrades to Neutral from Outperform - PT $44 (from $35)
• $Paramount Global-B(PARA.US$: Goldman Sachs Downgrades to Sell from Buy - PT $20 (from $37)
• $Roku Inc(ROKU.US$: Wolfe Research Downgrades to Underperform from Peerperform - PT $77
• $UBS Group(UBS.US$: BofA Securities Downgrades to Neutral from Buy - P...
16
1
Read more
Benjamin’s : New CEO